cgp 361a has been researched along with n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine in 1 studies
| Studies (cgp 361a) | Trials (cgp 361a) | Recent Studies (post-2010) (cgp 361a) | Studies (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) | Trials (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) | Recent Studies (post-2010) (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) |
|---|---|---|---|---|---|
| 21 | 3 | 3 | 81 | 0 | 37 |
| Protein | Taxonomy | cgp 361a (IC50) | n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.461 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.1 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.1 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.935 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.272 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cambj-Sapunar, L; Harder, DR; Roman, RJ; Yu, M | 1 |
1 other study(ies) available for cgp 361a and n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine
| Article | Year |
|---|---|
Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Topics: Amidines; Animals; Blood; Brain Ischemia; Calcium Signaling; Cerebrospinal Fluid; Cerebrovascular Circulation; Cisterna Magna; Eicosanoic Acids; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Injections; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Phospholipases A; Propanolamines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Subarachnoid Hemorrhage; Vascular Resistance; Vasoconstriction; Vasospasm, Intracranial | 2003 |